Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.

Autor: Francini E; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Montagnani F; Department of Oncology, Ospedale degli Infermi, Biella, Italy., Nuzzo PV; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Gonzalez-Velez M; Genomic Oncology Clinic, Mayo Clinic, Phoenix, Arizona., Alimohamed NS; Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Rosellini P; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy., Moreno-Candilejo I; Medical Oncology Unit, Hospital HM Sanchinarro Start, Madrid, Spain., Cigliola A; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy., Rubio-Perez J; University Hospital Fundacion Jimenez Diaz, Autonomous University of Madrid, Madrid, Spain., Crivelli F; Department of Oncology, Ospedale degli Infermi, Biella, Italy., Shaw GK; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Zhang L; DFCI at Geisinger Medical Center, Danville, Pennsylvania., Petrioli R; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy., Bengala C; Medical Oncology Unit, Misericordia Hospital, Grosseto, Italy., Francini G; Department of Medical and Surgical Sciences and Neuroscience, University of Siena, Siena, Italy., Garcia-Foncillas J; University Hospital Fundacion Jimenez Diaz, Autonomous University of Madrid, Madrid, Spain., Sweeney CJ; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Higano CS; Fred Hutchinson Cancer Research Center, University of Washington, Seattle., Bryce AH; Genomic Oncology Clinic, Mayo Clinic, Phoenix, Arizona., Harshman LC; Lank Center for Genitourinary Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Lee-Ying R; Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada., Heng DYC; Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, Alberta, Canada.

Publikováno v: JAMA network open [JAMA Netw Open] 2021 Jul 01; Vol. 4 (7), pp. e2116536. Date of Electronic Publication: 2021 Jul 01.

Disparities in Stage at Diagnosis among Hispanic Patients with Gastric Cancer in the United States.

Autor: Jeri-Yabar, Antoine¹ (AUTHOR) antoine.jeri@mountsinai.org, Vittini-Hernandez, Liliana¹ (AUTHOR), Aller-Rojas, Renzo² (AUTHOR) francisco.reyes.al@gmail.com, Arias-Reyes, Francisco² (AUTHOR), Dharmapuri, Sirish³ (AUTHOR) siirish.dharmapuri@gmail.com

Publikováno v: Cancers. Oct2024, Vol. 16 Issue 19, p3308. 12p.

Prediction of immunomodulatory drugs (IMiDs) sensitivity in myeloma via determination of baseline anti-oxidative stress capacity.

Autor: Mountjoy L; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA., Sebastian S; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA., Jain T; Hematologic Malignancies and Bone Marrow Transplantation Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hilal T; Division of Hematology and Medical Oncology, University of Mississippi Medical Center, Jackson, MS, USA., Gonzalez-Velez M; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA., Girardo M; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Phoenix, AZ, USA., Ahmann G; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA., Larsen J; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA., Bergsagel L; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA., Fonseca R; Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ, USA. fonseca.rafael@mayo.edu.

Publikováno v: Leukemia [Leukemia] 2020 Nov; Vol. 34 (11), pp. 3060-3063. Date of Electronic Publication: 2020 Jun 05.

Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration.

Autor: Hilal T; Division of Hematology-Oncology, University of Mississippi Medical Center, Jackson., Gonzalez-Velez M; Division of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona., Prasad V; Knight Cancer Institute, Division of Hematology Oncology, Oregon Health & Science University, Portland.; Department of Public Health and Preventive Medicine, Oregon Health & Science University, Portland.; Center for Health Care Ethics, Oregon Health & Science University, Portland.

Publikováno v: JAMA internal medicine [JAMA Intern Med] 2020 Aug 01; Vol. 180 (8), pp. 1108-1115.

Evaluating Unconscious Bias: Speaker Introductions at an International Oncology Conference.

Autor: Duma N; University of Wisconsin Carbone Cancer Center, Madison, WI., Durani U; Mayo Clinic, Rochester, MN., Woods CB; Crescent Community Health Center, Dubuque, IA., Kankeu Fonkoua LA; Mayo Clinic, Rochester, MN., Cook JM; Mayo Clinic, Rochester, MN., Wee C; Mayo Clinic, Rochester, MN., Fuentes HE; Mayo Clinic, Rochester, MN., Gonzalez-Velez M; Mayo Clinic, Scottsdale, AZ., Murphy MC; University of Florida, Gainesville, FL., Jain S; Rush University Medical Center, Chicago, IL., Marshall AL; Mayo Clinic, Rochester, MN., Graff SL; Sarah Cannon Cancer Institute, HCA Midwest Health, Kansas City, MO., Knoll MA; John Theurer Cancer Center, Hackensack, NJ.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Dec 20; Vol. 37 (36), pp. 3538-3545. Date of Electronic Publication: 2019 Oct 11.